MG
YCBD icon

Michael Gelband’s cbdMD YCBD Stock Holding History

Michael Gelband’s Portfolio YCBD Stock Details YCBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-399
Closed -$32K – 2214
2022
Q3 		$32K Buy
+399
New +$57.3K ﹤0.01% 1804
2022
Q1 		– Sell
-32
Closed -$12K – 2734
2021
Q4 		$12K Buy
+32
New +$18.6K ﹤0.01% 2099
2021
Q2 		– Sell
-121
Closed -$181K – 2877
2021
Q1 		$181K Buy
121
+89
+278% +$129K ﹤0.01% 1892
2020
Q4 		$34K Buy
+32
New +$29.1K ﹤0.01% 1886

Other funds holding YCBD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Merlin Capital Newport, Rhode Island $33.5M AUM 36.34% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.25B AUM 22.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIM
Cambria Investment Management Manhattan Beach, California $2.02B AUM 35.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Michael Gelband's YCBD Position: Q4 2022 in Review

Michael Gelband sold out of cbdMD (YCBD) in Q4 2022, closing a stake of 399 shares — an estimated $32K sold.

Michael Gelband first reported a position in YCBD in Q4 2020 and held it in 4 quarters. The position peaked at $181K in Q1 2021. 43 funds tracked by Wall St. Rank hold YCBD as of Q4 2022.

  • Michael Gelband reported no remaining cbdMD position as of Q4 2022 after selling out during the quarter.
  • Michael Gelband sold 399 cbdMD shares in Q4 2022, an estimated $32K.
  • Michael Gelband first reported a position in cbdMD in Q4 2020 and held it in 4 quarters.
  • Michael Gelband's cbdMD position peaked at $181K in Q1 2021.
  • 43 funds tracked by Wall St. Rank held cbdMD as of Q4 2022.

Based on ExodusPoint Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.